Home  »  Technology   »  Ironwood Pharmaceuticals Inc. (IRWD): The long ter...

Ironwood Pharmaceuticals Inc. (IRWD): The long term indicators on the stock call for a Buy today

How have the shares performed?

Ironwood Pharmaceuticals Inc. (IRWD) saw an uptrend of 1.31% in the recent trading with $12.00 being its most recent. The current price level -4.38% lower than the highest price of $12.55 marked by the stock while trading over the past 52-weeks, whereas it is 39.05% higher than the lowest price of $8.63 the company dropped to over past 52-weeks. The latest news story on IRWD appeared in Business Wire under the title “Ironwood Pharmaceuticals to Present New Linaclotide Data and Unveil Findings From GI Disease Surveys at Digestive Disease Week® 2021” on May-17-21.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Squeezing the time span to 30 day period shows us the stock is currently trading -1.23% below one month high and is +16.56% above of the lowest during that time. Looking into the simple moving average, Ironwood Pharmaceuticals Inc. (IRWD)’s stock stands at a SMA-50 of $10.98 while that of 5-day is reading $11.63.

Daily rise and fall of price influence many of the traders, and in order to overcome the fluctuating effect of that and to watch the stock closely, traders focus more on stock’s 200-day moving average. At various points in trading activity, investors are more likely to be making use of that measure as a strong indicator in figuring out their support and resistance levels, and IRWD’s SMA-200 as of now is $10.62.

Do analysts rate it as a buy, sell or hold?

Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Moderate Buy by 5 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 2.40 for the stock.

Ironwood Pharmaceuticals Inc. Earnings – What Happened With IRWD

Coming around sales and income figures, publically trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor. Ironwood Pharmaceuticals Inc. (IRWD) last released financial results for the quarter that ended 3/31/2021, posting a surprise factor of 14.30% for net revenue. During the reported three-month period, company’s sales were $116.68 billion while analysts on average were estimating the same to be $92.97 million.

IRWD – Ironwood Pharmaceuticals Inc. Stock Earnings Estimates

The perspective of Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD)’s current quarter earnings identifies that analysts are in consensus over the estimate of 0.21 for stock’s EPS in the current quarter. 5 analysts covering the stock at Wall Street were agreed upon that EPS consensus. Company’s EPS for the last quarter was 0.24.

Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 160.97 million.

Ironwood Pharmaceuticals Inc. – Insider Activity and Holdings

Moreover, the latest SEC filings also revealed that stock came across 15 new insider purchases involving 643,590 shares. On the other hand, IRWD declared 175,573 shares have been sold in 21 insider transactions over the past three months.

As on Mar 31, 2021, Wellington Management Group, LLP was the top most holder in Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) with an ownership of 21.19 million shares of the company or 13.08% of the stake worth $236.9 million. The filing also reveals Brown Capital Management, Inc. as the second largest holder in the company with a control over 12.45% of the outstanding shares. Its stake is worth $225.5 million for having 20.17 million shares in hand.

Sarissa Capital Management, LP also came holding a key position in the company during the recent quarter and it now holds 10.12% of the outstanding shares. With this there are now 310 institutions which have possession in IRWD’s shares.

Currently, the stock has been recommended as Moderate Buy by 5 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 2.40 for the stock.

The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, current ratio recorded by Ironwood Pharmaceuticals Inc. was 15.41 while posting a debt to equity ratio of 0.00. The count was 719.31 for long-term debt to equity ratio.

Ironwood Pharmaceuticals Inc.’s return on equity, or ROE, is 402.50%, compared to the industry average of 4.00% for Healthcare – Drug Manufacturers – Specialty & Generic. Although this indicates that IRWD uses its equity well, the metric will vary significantly depending on the industry.

Technical Analysis of Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) stock

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for Ironwood Pharmaceuticals Inc. (IRWD), we notice that the stock’s 20-day average volume is at 1,668,235 shares and 100% of short term indicators are suggesting the stock as Buy. Medium term indicators at an average of 100% are spotting the stock at Buy with its 50-day average volume of 1,895,288 shares. And to end, IRWD’s 100-day average volume is 1,939,647 shares with 100% of the long-term indicators pointing towards Buy for the stock.

Leave a Comment

Your email address will not be published. Required fields are marked *

More Posts

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam